Lubiprostone clinical trials
Also written Amitiza.
How each study uses Lubiprostone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Lubiprostone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 31 Jan 2006 · AMITIZA · NDA 021908 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
47 studies that test it; most in 2007 (7)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2007 | 7 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 7 |
| 2011 | 3 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 5 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 19 · Other 28
Sucampo Pharma Americas, LLC (13) · Takeda (3) · University of South Alabama (2) · Augusta University (2) · Texas Tech University Health Sciences Center, El Paso (2) · Mayo Clinic (2) · Brooke Army Medical Center (2) · University of Arkansas (2)
Often tested with
Tested in the same studies.
Polyethylene Glycols (1) · Polyethylene glycol 3350 (1) · Bisacodyl (1) · Golytely (1) · Maintenance Therapy (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 1 in phase 3
Studies that test Lubiprostone, phase 3 first.
- Oct 2027Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit ConstipationPhase 3 · Third Military Medical University
- Jun 2027Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal CancerPhase 2 · Sun Yat-sen University
Studies
Open first, then newest update. How each study uses Lubiprostone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 47
- Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit ConstipationRecruitingPhase 3Third Military Medical UniversityNCT07277907Written as Lubiprostone
- Lubiprostone Combined With Maintenance Therapy for Prevention of Postoperative Recurrence in Peritoneal Metastatic Colorectal CancerNot yet recruitingPhase 2Sun Yat-sen UniversityNCT07405736Written as maintenance therapy plus lubiprostone
- Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver DiseaseCompletedPhase 3Helwan UniversityNCT05768334Written as Lubiprostone 24Mcg Oral twice daily
- Lubiprostone as a Modulator of Gut Microbial Translocation in HIV With Incomplete CD4 Recovery on Antiretroviral TherapyCompletedPhase 2Ruth M. Rothstein CORE CenterNCT01839734Written as Lubiprostone
- Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy PreparationCompletedPhase 4Henry Ford Health SystemNCT00645801Written as lubiprostone (Amitiza)
- Amitiza in Constipation Associated With PD (Parkinson's Disease)CompletedPhase 4Baylor College of MedicineNCT00908076Written as LUBIPROSTONE
- Colon Preparation With 2L PEG in Combination With Lubiprostone vs 4L PEGCompletedPhase 4Rajavithi HospitalNCT04138004Written as polyethylene glycol in combination with lubiprostone
- Comparison of Lubiprostone and Placebo for the Relief of Constipation From Constipating MedicationsTerminatedPhase 4University of South AlabamaNCT01096290Written as lubiprostone
- Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule EndoscopyCompletedPhase 4University of South AlabamaNCT00746395Written as Lubiprostone
- Lubiprostone in Children With Functional ConstipationCompletedPhase 3Sucampo Pharma Americas, LLCNCT02042183Written as Lubiprostone
- Evaluation of the Safety of Lubiprostone in Pediatric Participants Aged ≥ 6 Years to < 18 Years With Functional ConstipationCompletedPhase 3Sucampo Pharma Americas, LLCNCT02766777Written as Lubiprostone
- Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy VolunteersCompletedPhase 3Sucampo Pharma Americas, LLCNCT03010631Written as Cohort 1: Lubiprostone Capsule, Fasted
- Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL)CompletedPhase 3Sucampo Pharma Americas, LLCNCT01298219Written as Lubiprostone
- Lubiprostone for Children With ConstipationCompletedPhase 3Sucampo Pharma Americas, LLCNCT02138136Written as Lubiprostone
- Opioid-induced Bowel Dysfunction: Long-Term Assessment of LubiprostoneCompletedPhase 3Sucampo Pharma Americas, LLCNCT00620061Written as Lubiprostone 24
- Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to PlaceboCompletedPhase 3Sucampo Pharma Americas, LLCNCT03097861Written as Lubiprostone
- Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel SyndromeTerminatedPhase 2Sucampo Pharma Americas, LLCNCT02544152Written as Lubiprostone
- Safety and Efficacy of Lubiprostone in Pediatric Patients With ConstipationCompletedPhase 4Sucampo Pharma Americas, LLCNCT00452335Written as Lubiprostone
- Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With ConstipationCompletedPhase 3Sucampo Pharma Americas, LLCNCT00399542Written as Lubiprostone
- Opioid-induced Bowel Dysfunction: Pivotal Assessment of LubiprostoneCompletedPhase 3Sucampo Pharma Americas, LLCNCT00595946Written as Lubiprostone
See all 47 studies that test Lubiprostone →
As the comparator · 1 — what is tested is compared with Lubiprostone
Codes
What other systems call Lubiprostone · ClinicalTrials.gg INT006502
- MeSH (NLM) D000068238LubiprostoneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7662KG2R6KLUBIPROSTONEConfirmed FDA, NLM, Wikidata
- RxNorm 623033Confirmed FDA, Wikidata
- Wikidata Q6695342lubiprostoneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66040LubiprostoneConfirmed FDA, Wikidata
- DrugBank DB01046One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068238 | Lubiprostone | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7662KG2R6K | LUBIPROSTONE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 623033 | — | Confirmed FDA, Wikidata |
| Wikidata | Q6695342 | lubiprostone | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66040 | Lubiprostone | Confirmed FDA, Wikidata |
| DrugBank | DB01046 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.